MedPath

Argatroban

These highlights do not include all the information needed to use ARGATROBAN INJECTION safely and effectively. See full prescribing information for ARGATROBAN INJECTION. ARGATROBAN injection, for intravenous infusion only Initial U.S. Approval: 2000

Approved
Approval ID

990b046f-bfd8-496c-ac58-8c7d79257c5c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 10, 2022

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Argatroban

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-1140
Application NumberANDA204120
Product Classification
M
Marketing Category
C73584
G
Generic Name
Argatroban
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 15, 2019
FDA Product Classification

INGREDIENTS (3)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
ARGATROBANActive
Quantity: 100 mg in 1 mL
Code: IY90U61Z3S
Classification: ACTIB
SORBITOLInactive
Code: 506T60A25R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Argatroban - FDA Drug Approval Details